ABSTRACT BACKGROUND Data suggest that T 1 and T 2 mapping have excellent diagnostic accuracy in patients with suspected
. However, EMB is an invasive procedure with a risk of relevant complications and is not widely available.
Tremendous efforts have been undertaken to use cardiac magnetic resonance (CMR) imaging to diagnose myocarditis (6) (7) (8) (9) (10) (11) . One approach is the proposed Lake Louise criteria (LLC) (11) , consisting of lateenhancement sequences, T 2 -weighted edema images, and T 1 -weighted sequences before and after contrast injection (early enhancement). Although helpful, especially in patients with angina-like symptoms and recent symptom onset, the LLC are insufficient when applied in patients with heart failure (HF) symptoms and chronic manifestation (12) (13) (14) . However, most CMR studies were performed on 1.5-T scanners. The potential benefit of increased signal when using these sequences on a 3-T scanner remains unknown.
Recently, novel quantitative T 1 and T 2 mapping techniques, including the quantification of extracellular volume (ECV), have been suggested to overcome some limitations of the LLC, creating high expectations about their diagnostic utility (13, (15) (16) (17) (18) . However, the majority of T 1 and T 2 mapping studies compared CMR results of patients with suspected myocarditis with healthy control subjects (13, (15) (16) (17) .
The true diagnostic performance of the latest CMR techniques in patients with various pathologies, with EMB serving as the reference standard, has been determined in a single recently published trial in a small population of patients (18) . Therefore, we sought to assess the diagnostic performance of a comprehensive CMR protocol, including the LLC, native T 1 mapping, quantification of ECV, and T 2 mapping on a 1.5-T scanner in a large, unselected, consecutive patient cohort in comparison with biventricular EMB. We also evaluated the potential role of CMR field strength in diagnostic accuracy by comparing CMR imaging results using 1.5-and 3-T. The study was approved by the local ethics committee, and all patients gave written informed consent.
IMAGING, BIOPSY, AND IMMUNOHISTOLOGICAL
ACQUISITION AND ANALYSES. CMR was performed using a 1.5-T scanner (Intera CV, Philips, Best, the Netherlands) and 3-T scanner (Verio, Siemens Healthcare, Erlangen, Germany). The CMR protocol consisted of cine sequences, T 2 -weighted short-tau inversion-recovery (T2w), T 1 -weighted spin-echo (T1w), and phase-sensitive inversion recovery (PSIR) imaging for late enhancement assessment after intravenous administration of 0.15 mmol gadobutrol per kg of body weight. T 2 mapping was performed before contrast media application with free-breathing, navigator-gated multi-echo sequence. T 1 mapping was performed with a modified Look-Locker inversion recovery sequence using a 3(3)5 scheme before and 15 min after contrast application. Cine and mapping were acquired in vertical long-axis, horizontal long-axis, and short-axis orientations; T1w in transversal; and T2w and PSIR in short-axis orientation.
Cine, T2w, T1w, and PSIR were realized as multislice stacks, covering the whole LV, whereas mapping was performed as single slices. Histological, immunohistological, and molecular pathological analyses were performed as previously described (4, 6, 10, 12, 19, 20) 28% to 54%; p < 0.001).
Patients presenting with acute symptoms had a higher frequency of elevated creatine kinase-MB and C-reactive protein levels, whereas troponin was similar between groups.
EMB ANALYSIS. Biventricular EMB was performed in 93% of patients (120 of 129). In 6 patients, only RV specimens were obtained and in 3, only LV specimens were available for analysis. Per EMB results ( Table 2) , myocarditis was the most common diagnosis on EMB analysis, with no differences between the acute and chronic groups (70% vs. Native T 1 mapping yielded the highest diagnostic accuracy (81%) followed by T 2 mapping (80%), ECV (75%), and LLC (59%) ( Table 4 ).
In patients with chronic symptoms, conventional imaging techniques included within the LLC did not allow for differentiation between EMB-proven myocarditis and absence of inflammation ( Figure 2 ).
Importantly, values of native T 1 mapping and ECV calculation did not differ between patients with and without myocarditis. Only values of T 2 mapping
were significantly different between groups ( Table 3) . Values are median (interquartile range) or n (%), unless otherwise indicated. *Values were only compared in patients with elevated levels.
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The AUC for T 2 mapping was superior to LLC
The highest diagnostic accuracy was achieved by T 2 (73%) followed by ECV (67%), LCC (59%), and native T 1 mapping (45%) ( Table 4) . Comparison of patients with myocarditis and acute versus chronic symptoms demonstrated no differences in native Table 3) .
RESULTS OF 3-T CMR IMAGING.
Of 129 patients within the 1.5-T population, 111 underwent subsequent 3-T CMR imaging ( Figure 1 provides the reasons why 18 did not).
Results of 3-T imaging in patients with acute and chronic symptoms mirrored those of 1.5-T imaging apart from results of T 2 mapping, which was inadequate on 3-T due to technical reasons and therefore excluded from the study. Values for native T 1 and ECV, but not LLC, were significantly higher in patients with acute symptoms and EMB-proven myocarditis than in patients with no myocarditis in EMB ( Table 3) . 
Lurz et al. Lurz et al. Values are % (interquartile range) unless otherwise indicated.
NPV ¼ negative predictive value; PPV ¼ positive predictive value; other abbreviations as in Table 3 . In acute patients, the areas under the curve (AUCs) were significantly higher for native T 1 (p ¼ 0.002), extracellular volume fraction (ECV) (p ¼ 0.04), and T 2 (p ¼ 0.001) as compared to Lake Louise criteria (LLC) with no significant differences between mapping techniques.
In patients with chronic symptoms, the AUC for T 2 mapping was superior to LLC (p ¼ 0.002) and native T 1 (p ¼ 0.04).
Lurz et al. well to what has been described previously (17) . 
CONCLUSIONS
Our results suggested that duration of symptoms is crucial when using CMR techniques to confirm or reject myocarditis. This seemed to be a consequence of the shift in inflammatory pathology over the disease course. Native T 1 mapping and ECV were helpful in patients with acute symptoms and suspected myocarditis, but only T 2 mapping added significantly to LCC when assessing patients with chronic symptoms. There was no effect of CMR field strength on diagnostic accuracy in our patient population. However, the exact effect of CMR field strength requires further evaluation before definite conclusions can be drawn. 
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